Clinical significance of antiproteinase 3 antibody positivity in cANCA-positive patients

Citation
V. Van Pesch et al., Clinical significance of antiproteinase 3 antibody positivity in cANCA-positive patients, CLIN RHEUMA, 18(4), 1999, pp. 279-282
Citations number
16
Categorie Soggetti
Rheumatology
Journal title
CLINICAL RHEUMATOLOGY
ISSN journal
07703198 → ACNP
Volume
18
Issue
4
Year of publication
1999
Pages
279 - 282
Database
ISI
SICI code
0770-3198(1999)18:4<279:CSOA3A>2.0.ZU;2-V
Abstract
We addressed the clinical significance of antiproteinase 3 (anti-PR3) antib ody (Ab) positivity by reviewing the files of 79 patients whose serum conta ined antineutrophil cytoplasmic antibodies with a cytoplasmic staining patt ern (cANCA) and had been tested for anti-PR3 reactivity, Vasculitis was pre sent in most (22/35) cANCA(+) PR3(+) patients but in only a few (5/44) cANC A(+) PR3(-) patients, thereby suggesting that anti-PR3 Ab positivity in cAN CA(+) patients is more indicative of vasculitis than cANCA positivity alone . Noteworthy, one-third of cANCA(+) PR3(+) patients - those with anti-PR3 A b titres lower than 100 U/ml - did not suffer from vasculitis. Anti-PR3 rea ctivity in vasculitis patients was only weakly associated with Wegener's gr anulomatosis (WG), as nine out of 22 cANCA(+) PR3(+) vasculitis patients (4 1%) did not fulfil the ACR classification criteria for WG. There was no cor relation between anti-PR3 Ab titres and disease activity at diagnosis. Howe ver, titres measured when patients were in remission were much lower than i nitial values. Taken together, our results indicate that anti-PR3 Ab positi vity should be interpreted in its clinical context.